Cargando…
A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I–III colon cancer
BACKGROUND: Tumour microenvironment (TME) is critical for the regulation of cancer development as well as therapy. The objective of the current study was the development of a robust prognostic model based on TME-relevant genes. METHODS: Five public microarray datasets providing clinical information...
Autores principales: | Zhou, Rui, Zeng, Dongqiang, Zhang, Jingwen, Sun, Huiying, Wu, Jianhua, Li, Nailin, Liang, Li, Shi, Min, Bin, Jianping, Liao, Yulin, Huang, Na, Liao, Wangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491960/ https://www.ncbi.nlm.nih.gov/pubmed/30917936 http://dx.doi.org/10.1016/j.ebiom.2019.03.043 |
Ejemplares similares
-
Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
por: Zhou, Rui, et al.
Publicado: (2018) -
A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer
por: Zhou, Rui, et al.
Publicado: (2020) -
Immunosuppressive Microenvironment Revealed by Immune Cell Landscape in Pre-metastatic Liver of Colorectal Cancer
por: Zeng, Dongqiang, et al.
Publicado: (2021) -
Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer
por: Zhou, Rui, et al.
Publicado: (2022) -
Expression pattern of secretory‐cell‐related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes
por: Zhou, Rui, et al.
Publicado: (2022)